![Mohamad Takwa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohamad Takwa
Amministratore Delegato presso
Thyrolytics AB
Profilo
Mohamad Takwa is the founder of Epigenica AB, serving as Chief Executive Officer since 2020.
Current jobs include Chief Executive Officer at Thyrolytics AB and Director at Glycolink AB starting in 2024.
Former job includes Chief Executive Officer at Bioextrax AB.
Posizioni attive di Mohamad Takwa
| Società | Posizione | Inizio |
|---|---|---|
Thyrolytics AB
 Thyrolytics AB Medical/Nursing ServicesHealth Services Operates as a diagnostics company | Amministratore Delegato | - |
Glycolink AB
 Glycolink AB Internet Software/ServicesTechnology Services Operates as hydrogel based technology platform | Direttore/Membro del Consiglio | 01/04/2024 |
Precedenti posizioni note di Mohamad Takwa
| Società | Posizione | Fine |
|---|---|---|
| BIOEXTRAX AB | Amministratore Delegato | 24/09/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Bioextrax AB
 Bioextrax AB BiotechnologyHealth Technology Develops and commercializes bio-extraction platform technology | Health Technology |
Thyrolytics AB
Thyrolytics AB Medical/Nursing ServicesHealth Services Operates as a diagnostics company | Health Services |
Glycolink AB
Glycolink AB Internet Software/ServicesTechnology Services Operates as hydrogel based technology platform | Technology Services |
